A new long-term study has found that many people with Parkinson’s disease are already using mental health medications even before they are diagnosed.
The research suggests that symptoms affecting mood, sleep, and thinking may begin earlier than most people realize, long before the well-known movement problems appear.
Parkinson’s disease is a condition that affects the brain and becomes worse over time. It is often linked to symptoms such as shaking, slow movement, and stiffness. These physical signs are usually what lead to diagnosis.
However, the disease also affects other parts of the brain that control emotions, sleep, and pain. These less visible symptoms are sometimes called non-motor symptoms.
The study was carried out by researchers at the University of Eastern Finland and published in the British Journal of Clinical Pharmacology. It is one of the first studies to follow people over a long period of time to understand how the use of certain medications changes before and after a Parkinson’s diagnosis.
The researchers looked at health records from Finland and followed more than 17,000 people with Parkinson’s disease. They also compared them to over 115,000 people of similar age and background who did not have the disease. The study covered a total of ten years, including five years before diagnosis and five years after.
The results showed that people with Parkinson’s disease were more likely to use psychotropic medications than those without the disease. These medications are used to treat conditions such as anxiety, depression, sleep problems, and other mental health issues.
At the start of the study, about 18 percent of people who would later be diagnosed with Parkinson’s were already using at least one psychotropic medication. This number increased to 35 percent over time. In comparison, among people without Parkinson’s disease, usage rose from 14 percent to 20 percent.
The study also found that using more than one type of these medications at the same time became more common. At the beginning, about 5 percent of people with Parkinson’s were taking multiple psychotropic drugs. By the end of the study, this number had doubled to 10 percent.
Another important finding was that medication use increased with age. People aged 80 and older were the most likely to use these drugs in both groups. This is not surprising, as older adults often have more health problems and may need more treatment.
The types of medications used also changed over time. Drugs used to treat anxiety and sleep problems were the most common at first. However, after a few years following diagnosis, antidepressants became even more widely used among people with Parkinson’s disease.
The researchers believe these patterns show that non-motor symptoms are an important part of Parkinson’s disease. These symptoms may appear early and become worse as the disease progresses. Because of this, people may seek medical help for these problems even before they are diagnosed with Parkinson’s.
While these medications can be helpful, the study also raises concerns. Taking multiple psychotropic drugs can increase the risk of side effects, especially in older adults. One major risk is falling, which can lead to serious injuries such as fractures. People with Parkinson’s disease already have a higher risk of falls due to balance and movement problems.
This means that doctors need to be careful when prescribing these medications. They must balance the benefits of treating symptoms with the risks of side effects. Regular check-ups and careful monitoring are important to ensure patient safety.
In conclusion, this study shows that Parkinson’s disease affects more than just movement. It highlights the importance of recognizing early symptoms and providing proper care. However, it also reminds us that treatment choices should be made carefully, especially for older patients.
The study provides valuable long-term data, but it is based on health records and cannot fully explain why people were prescribed these medications. More research is needed to understand how best to manage these symptoms while reducing risks. Even so, the findings offer important insights into the early stages of Parkinson’s disease and how it is treated.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more health information, please see recent studies about how wheat gluten might be influencing our brain health, and Olive oil: a daily dose for better brain health..
Source: University of Eastern Finland.
